<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04916041</url>
  </required_header>
  <id_info>
    <org_study_id>21/365-O_P</org_study_id>
    <nct_id>NCT04916041</nct_id>
  </id_info>
  <brief_title>Visual Function in Subjects Implanted With Advanced Technology Intraocular Lenses</brief_title>
  <official_title>Visual Function in Subjects Implanted With Advanced Technology Intraocular Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clínica Rementería</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clínica Rementería</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple intraocular lens are nowadays available for implantation after cataract surgery.&#xD;
      They use different technology to try to improve patient spectacle independence. It is&#xD;
      necessary to better characterise the performence of each type of lens, as well as to define&#xD;
      how they are affected by residual refractive errors. The purpose of this study is to evaluate&#xD;
      visual function in patients implanted with different lenses (advanced monofocals, trifocals)&#xD;
      in order to be able to recommend the best type of lens for each patient.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intermediate binocular uncorrected visual acuity</measure>
    <time_frame>3-9 months after cataract surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Distance binocular uncorrected visual acuity</measure>
    <time_frame>3-9 months after cataract surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Near binocular uncorrected visual acuity</measure>
    <time_frame>3-9 months after cataract surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Binocular contrast sensitivity</measure>
    <time_frame>3-9 months after cataract surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Halo perception</measure>
    <time_frame>3-9 months after cataract surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported visual function questionnaires</measure>
    <time_frame>3-9 months after cataract surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Lenses, Intraocular</condition>
  <arm_group>
    <arm_group_label>Vivity</arm_group_label>
    <description>Patients who have undergone bilateral implantation of Vivity intraocular lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eyhance</arm_group_label>
    <description>Patients who have received bilateral implantation of an Eyhance intraocular lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EMV</arm_group_label>
    <description>Patients who have undergone bilateral implantation of Vivity intraocular lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Panoptix</arm_group_label>
    <description>Patients who have undergone bilateral implantation of Panoptix intraocular lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rayner Trifocal</arm_group_label>
    <description>Patients who have undergone bilateral implantation of Rayner trifocal intraocular lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cataract surgery with bilateral implantation of the same type of intraocular lens</intervention_name>
    <description>Cataract surgery with bilateral implantation of the same type of intraocular lens</description>
    <arm_group_label>EMV</arm_group_label>
    <arm_group_label>Eyhance</arm_group_label>
    <arm_group_label>Panoptix</arm_group_label>
    <arm_group_label>Rayner Trifocal</arm_group_label>
    <arm_group_label>Vivity</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have undergone bilateral cataract surgery between three and nine months prior&#xD;
        to study procedures, with bilateral implantation of one of the intraocular lens models&#xD;
        included in the study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Bilateral cataract surgery Bilateral implantation of one of the&#xD;
        intraocular lens models included in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Intrasurgical complications Postsurgical complications Ophthalmological disease that limits&#xD;
        visual potential as estimated by investigator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clínica Rementería</name>
      <address>
        <city>Madrid</city>
        <zip>28010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inés Contreras</last_name>
      <phone>34913080808</phone>
      <email>contreras@clinicarementeria.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 1, 2021</study_first_submitted>
  <study_first_submitted_qc>June 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2021</study_first_posted>
  <last_update_submitted>June 1, 2021</last_update_submitted>
  <last_update_submitted_qc>June 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

